Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis

被引：30

作者：

Burkhardt, Olaf ^{[1
]}

Joukhadar, Christian ^{[2
]}

Traunmueller, Friederike ^{[2
]}

Hadem, Johannes ^{[3
]}

Welte, Tobias ^{[1
]}

Kielstein, Jan T. ^{[1
]}

机构：

[1] Hannover Med Sch, Dept Pulm Med, D-3000 Hannover, Germany

[2] J&P Med Res Ltd, Vienna, Austria

[3] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2008年 / 61卷 / 01期

关键词：

gram-positive infections; endocarditis; renal replacement therapy;

D O I：

10.1093/jac/dkm405

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：224 / 225

页数：3

共 8 条

[1] Daptomycin clearance during modeled continuous renal replacement therapy [J].

Churchwell, Mariann D. ;

Pasko, Deborah A. ;

Mueller, Bruce A. .

BLOOD PURIFICATION, 2006, 24 (5-6) :548-554

[2] Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis [J].

Czock, David ;

Huesig-Linde, Cordula ;

Langhoff, Anita ;

Schoepke, Timo ;

Hafer, Carsten ;

de Groot, Kirsten ;

Swoboda, Stefanie ;

Kuse, Ernst ;

Haller, Hermann ;

Fliser, Danilo ;

Keller, Frieder ;

Kielstein, Jan T. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (06) :1263-1268

[3] Population pharmacokineties of daptomycin [J].

Dvorchik, B ;

Arbeit, RD ;

Chung, J ;

Liu, S ;

Knebel, W ;

Kastrissios, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) :2799-2807

[4] Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects [J].

Dvorchik, BH ;

Brazier, D ;

DeBruin, MF ;

Arbeit, RD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) :1318-1323

[5] Technology Insight: treatment of renal failure in the intensive care unit with extended dialysis [J].

Fliser, D ;

Kielstein, JT .

NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (01) :32-39

[6] Daptomycin in the treatment of skin, soft-tissue and invasive infections due to Gram-positive bacteria [J].

Johnson, Alan .

FUTURE MICROBIOLOGY, 2006, 1 (03) :255-265

[7] Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis [J].

Kielstein, JT ;

Czock, D ;

Schöpke, T ;

Hafer, C ;

Bode-Böger, SM ;

Kuse, E ;

Keller, F ;

Fliser, D .

CRITICAL CARE MEDICINE, 2006, 34 (01) :51-56

[8] Postantibiotic effects of daptomycin against 14 staphylococcal and pneumococcal clinical isolates [J].

Pankuch, GA ;

Jacobs, MR ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) :3012-3014

← 1 →